Brokerages Set Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Target Price at $106.08
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the […]
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the […]
